A new pill called orforglipron may help individuals who stop using weight loss injections maintain their weight loss, with a study showing that those taking the pill for a year significantly prevented weight gain after discontinuing GLP-1 injections, although further research is needed to determine its long-term usage and effects. #ObesityManagement #WeightLoss #HealthResearch #US #GB
A new daily pill called orforglipron may help individuals transitioning off weight-loss injections maintain their weight loss, as a study found that those taking the pill maintained over 70% of their weight loss after one year compared to only 38-50% in the placebo group, with the drug expected to be more accessible than current injectable treatments. #WeightLoss #ObesityManagement #HealthResearch #US #UK
A new daily pill called orforglipron has been found to help individuals maintain their weight loss after discontinuing weight-loss injections, showing promising results in trials, while offering a potentially more convenient alternative to injections, and highlighting the need for ongoing treatment in managing obesity. #WeightLoss #ObesityManagement #HealthResearch #US #UK
The article emphasizes that obesity is a chronic, progressive, and multifactorial condition requiring continuous management rather than short-term solutions, highlighting the importance of long-term medication usage, such as semaglutide and tirzepatide, alongside lifestyle changes and multidisciplinary support to effectively control the disease and prevent weight regain. #ObesityManagement #ChronicDisease #HealthcareSolutions #BR #US
